PMS47 The Long Term Cost-Effectiveness of Golimumab for the Treatment of Severe, Active Ankylosing Spondylitis in Adults Who Have Responded Inadequately to Conventional Therapy
Abstract
Authors
J. Farrell N. Muszbek O. Sheppard M. Chaudhary H. Naci S. Kachroo